#EXP00005

General

Accession EXP00005
Activity Formation (3-24h)
Date 2013-11-08
Administration In solution
Model in vitro
Organism Stenotrophomonas maltophilia
Status Validated
Notes Sm109 clinical isolate

Peptide

SMAP-29

RGLRRLGRKIAHGVKKYGPTVLRIIRIA

Experimental activity

Method Concentration Notes
Crystal violet assay 0.626 uM Sm109 strain
Crystal violet assay 0.313 uM Sm143 strain
Crystal violet assay 0 uM Sm143 strain

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814